Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Faith E Davies

1-50 of 109 results

View this query on the Wikidata Query Service
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

scientific article
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

scientific article
Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study

scientific article published on 3 June 2013
Antimyeloma activity of heat shock protein-90 inhibition.

scientific article published on 18 October 2005
Guidelines for the diagnosis and management of multiple myeloma 2011

scientific article published on May 14, 2011
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms

scientific article published on 02 July 2013
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).

scientific article published on 12 August 2011
Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response

scientific article published on February 11, 2011
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis

scientific article published on October 20, 2011
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement

scientific article published on 20 January 2015
Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction

scientific article
Homozygous Deletion Mapping in Myeloma Samples Identifies Genes and an Expression Signature Relevant to Pathogenesis and Outcome

scientific article published on March 9, 2010
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.

scientific article published on 11 August 2016
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation

scientific article published in November 2002
Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients

scientific article
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

scientific article published on 08 June 2018
Long-term Follow-up of MRC Myeloma IX Trial: Survival Outcomes with Bisphosphonate and Thalidomide Treatment

scientific article published on August 30, 2013
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

scientific article published on 16 August 2017
European perspective on multiple myeloma treatment strategies in 2014

scientific article
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

scientific article published in January 2019
Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity

scientific article published in July 2004
Future directions of next-generation novel therapies, combination approaches, and the development of personalized medicine in myeloma.

scientific article published on 11 April 2011
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens

scientific article published on October 16, 2003
Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

scientific article published on 06 June 2017
The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment

scientific article
Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study

scientific article published on February 2014
Inhibiting MEK in MAPK pathway-activated myeloma

scientific article published on July 31, 2015
European perspective on multiple myeloma treatment strategies: update following recent congresses

scientific article
Heat shock proteins in multiple myeloma

scientific article published on March 2014
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

scientific article published on 14 December 2018
Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen

scientific article published on 15 October 2015
Aetiology of bone disease and the role of bisphosphonates in multiple myeloma

scientific article published on May 1, 2003
A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma

scientific article published in September 2004
The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma.

scientific article published on 27 May 2016
Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

scientific article published on 09 December 2015
Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

scientific article published on 24 February 2017
The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma.

scientific article published on 26 May 2017
How to manage neutropenia in multiple myeloma

scientific article published on 16 December 2011
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

scientific article
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma

scientific article published on 26 May 2017
Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma

scientific article published on March 11, 2014
A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma

scientific article
Minimal residual disease monitoring in multiple myeloma.

scientific article
Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma

scientific article published on May 5, 2015
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance

scientific article published on 21 January 2014
The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells

scientific article published on 5 December 2014
Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma

scientific article published on March 16, 2010
High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD

scientific article published on December 28, 2012
Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism

scientific article published in February 2003
Biology and treatment of myeloma

scientific article published on September 2014

Paulina is supported by:

About Paulina

Help